Cleared Traditional

K031110 - APEX MODULAR ACETABULAR CUP (FDA 510(k) Clearance)

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K031110 · Apex Surgical, LLC · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2003
Decision
44d
Days
Class 2
Risk

K031110 is an FDA 510(k) clearance for the APEX MODULAR ACETABULAR CUP. Classified as Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented (product code LPH), Class II - Special Controls.

Submitted by Apex Surgical, LLC (Lakeville, US). The FDA issued a Cleared decision on May 22, 2003 after a review of 44 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3358 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Apex Surgical, LLC devices

Submission Details

510(k) Number K031110 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 08, 2003
Decision Date May 22, 2003
Days to Decision 44 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
78d faster than avg
Panel avg: 122d · This submission: 44d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3358
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented

All 558
Devices cleared under the same product code (LPH) and FDA review panel - the closest regulatory comparables to K031110.
G7® Revision Acetabular System
K252623 · Zimmer, Inc. · Feb 2026
Mpact 3D Metal Implants Extension – DMLS Technology
K251043 · Medacta International S.A. · Jan 2026
Velora Acetabular System
K252067 · Restor3D, Inc. · Dec 2025
TaperSet™ Hip System
K252846 · Shalby Advanced Technologies, Inc. Dba Consensus Orthopedics · Nov 2025
EMPOWR Acetabular® Liner Extension
K251833 · Encore Medical, L.P. · Nov 2025
ArTT Augments and Buttresses and Bone Screws
K251718 · Lima Corporate S.P.A. · Aug 2025